Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lidia Ruiz

Showing results (101-110 of 164) with videos related to

Pageof 17
Sort By:
AIDS (London, England)|January 16, 2008
Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDAWendy P Bannister, Lidia Ruiz, Alessandro Cozzi-Lepri, et al.
Carcinogenesis|April 12, 2007
MAP17 overexpression is a common characteristic of carcinomasMaria V Guijarro, Juan F M Leal, Jesus Fominaya, et al.
BMC Biology|March 14, 2025
Rare but specific: 5-bp composite motifs define SMAD binding in BMP signalingJerome Jatzlau, Sophie-Nhi Do, Rebeca A Mees, et al.
Nature Communications|November 26, 2022
Molecular basis for DNA recognition by the maternal pioneer transcription factor FoxH1Radoslaw Pluta, Eric Aragón, Nicholas A Prescott, et al.
AIDS (London, England)|April 7, 2007
Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimenAlessandro Cozzi-Lepri, Andrew N Phillips, Lidia Ruiz, et al.
Journal of Leukocyte Biology|April 4, 2007
Skewed expression and up-regulation of the IL-12 and IL-18 receptors in resting and activated CD4 T cells from HIV-1-infected patientsGuillermo Robert de Arquer, Ruth Peña, Cecilia Cabrera, et al.
Antiviral Therapy|November 13, 2004
Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA studyCecilia Cabrera, Alessandro Cozzi-Lepri, Andrew N Phillips, et al.
The Journal of Infectious Diseases|September 27, 2003
Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene StudyLidia Ruiz, Esteban Ribera, Anna Bonjoch, et al.
AIDS (London, England)|January 2, 2007
Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patientsLidia Ruiz, Roger Paredes, Guadalupe Gómez, et al.
Nature Communications|December 1, 2023
Structural basis of a redox-dependent conformational switch that regulates the stress kinase p38αJoan Pous, Blazej Baginski, Pau Martin-Malpartida, et al.
Pageof 17

Showing results (101-110 of 164) with videos related to

Sort By:
Pageof 17
AIDS (London, England)|January 16, 2008
Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDAWendy P Bannister, Lidia Ruiz, Alessandro Cozzi-Lepri, et al.
Carcinogenesis|April 12, 2007
MAP17 overexpression is a common characteristic of carcinomasMaria V Guijarro, Juan F M Leal, Jesus Fominaya, et al.
BMC Biology|March 14, 2025
Rare but specific: 5-bp composite motifs define SMAD binding in BMP signalingJerome Jatzlau, Sophie-Nhi Do, Rebeca A Mees, et al.
Nature Communications|November 26, 2022
Molecular basis for DNA recognition by the maternal pioneer transcription factor FoxH1Radoslaw Pluta, Eric Aragón, Nicholas A Prescott, et al.
AIDS (London, England)|April 7, 2007
Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimenAlessandro Cozzi-Lepri, Andrew N Phillips, Lidia Ruiz, et al.
Journal of Leukocyte Biology|April 4, 2007
Skewed expression and up-regulation of the IL-12 and IL-18 receptors in resting and activated CD4 T cells from HIV-1-infected patientsGuillermo Robert de Arquer, Ruth Peña, Cecilia Cabrera, et al.
Antiviral Therapy|November 13, 2004
Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA studyCecilia Cabrera, Alessandro Cozzi-Lepri, Andrew N Phillips, et al.
The Journal of Infectious Diseases|September 27, 2003
Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene StudyLidia Ruiz, Esteban Ribera, Anna Bonjoch, et al.
AIDS (London, England)|January 2, 2007
Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patientsLidia Ruiz, Roger Paredes, Guadalupe Gómez, et al.
Nature Communications|December 1, 2023
Structural basis of a redox-dependent conformational switch that regulates the stress kinase p38αJoan Pous, Blazej Baginski, Pau Martin-Malpartida, et al.
Pageof 17